Skip Nav Destination
ISSN: 2666-2345
eISSN: 2590-017X
Indexed by: Web of Science (ESCI), PMC, Scopus, DOAJ, Crossref
About this Journal
JIPO publishes high-quality manuscripts that appeal to a broad readership of healthcare professionals and scientists, especially those with an interest in oncology and immunology. JIPO is indexed by Web of Science (ESCI), PubMed Central (PMC), Scopus, Directory of Open Access Journals (DOAJ), and Crossref.
Featured Content
RESEARCH ARTICLE | January 14 2025
Expert Clinical Management of Inflammatory Immune-Related Arthritis in Patients with Cancer Receiving Immune Checkpoint Inhibitors
RESEARCH ARTICLE | January 10 2025
Use of Immunoglobulin Replacement Therapy in Clinical Practice: A Review
REVIEW ARTICLE | January 15 2025
Selinexor (KPT-330) in Combination with Immune Checkpoint Inhibition in Uveal Melanoma: A Phase 1B Trial
PD-L1 Testing, Treatment Patterns, and Clinical Outcomes Among Patients with Metastatic NSCLC at an Academic Medical Center, 2017–2021
Mehmet Altan, Dawen Sui, Cai Xu, George R. Simon, Saliha T. Sulihem, Donna Malveaux, Darcy Ponce, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, J. Jack Lee, Jianjun Zhang, Don L. Gibbons, Ara A. Vaporciyan, John V. Heymach, Melissa L. Santorelli, Thomas Burke, Loretta A. Williams
Major Adverse Cardiovascular Events in Patients with Melanoma Receiving Immune Checkpoint Inhibitors
Juan I. Ruiz, Bo Zhao, Nicolas Palaskas, Anita Deswal, Hui Zhao, Jennifer McQuade, Maria E. Suarez-Almazor
Pembrolizumab in Patients with Advanced Miscellaneous Rare Cancers: Results from a Phase 2 Basket Trial
Mirella Nardo, Camila Braganca Xavier, Bettzy Stephen, Jeffrey A. How, Justin Moyers, Vivek Subbiah, David S. Hong, Aung Naing
Antibody-Drug Conjugate–Induced Pneumonitis: A Growing Threat
Kathy L. Chan, Saadia A. Faiz, Ajay Sheshadri
B7 Homolog 4 (B7-H4)-Directed Agents in Oncology Clinical Trials: A Review
Meave Phipps, Gerald S. Falchook